Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain

European Journal of Pharmacology

Volumn 623, Issue 1-3, 2009, Pages 65-72

  Mika, Joanna ^a   Osikowicz, Maria ^a   Rojewska, Ewelina ^a   Korostynski, Michal ^a   Wawrzczak Bargiela, Agnieszka ^a   Przewlocki, Ryszard ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

C1q; CD11b c; GFAP; Glia; Neuropathic pain; OX42

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C1Q; FLUOROCITRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MINOCYCLINE; PENTOXIFYLLINE; POLFILIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; COLD SENSITIVITY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MACROGLIA; MALE; MICROGLIA; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SPINAL CORD DORSAL HORN; TOUCH; UPREGULATION; WESTERN BLOTTING;

ANALGESICS; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CITRATES; COMPLEMENT C1Q; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; MACROPHAGE-1 ANTIGEN; MALE; MICE; MICROGLIA; MINOCYCLINE; NEURALGIA; NOCICEPTORS; ORGAN SPECIFICITY; PAIN MEASUREMENT; PENTOXIFYLLINE; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHODIESTERASE INHIBITORS; SPINAL CORD;

EID: 70350196359     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.030     Document Type: Article

References (72)

1. Amin A.R., Attur M.G., and Thakker G.D. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14014-14019
2. Aronson A.L. Pharmacotherapeutics of the newer tetracyclines. J. Am. Vet. Med. Assoc. 176 (1980) 1061-1068
3. Bennett G.J., and Xie Y. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Blum D., Chtarto A., Tenenbaum L., Brotchi J., and Levivier M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17 (2004) 359-366
5. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
6. Chen J., Zhang J., Zhao Y., Yuan L., Nie X., Li J., Ma Z., Zhang Y., Wang Q., Chen Y., Jin Y., and Rao Z. Hyperalgesia in response to traumatic occlusion and GFAP expression in rat correction of parabranchial nucleus: modulation with fluorocitrate. Cell Tissue Res. 329 (2007) 231-237
7. Choi Y., Yoon Y.W., Na H.S., Kim S.H., and Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59 (1994) 369-376
8. Colburn R.W., Rickman A.J., and DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 157 (1999) 289-304
9. Colovic M., and Caccia S. Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. Life Sci. 791 (2003) 337-343
10. Coyle D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23 (1998) 75-83
11. Cui Y., Liao X.X., and Liu W. A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav. Immun. 22 (2008) 114-123
12. DeLeo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist. 10 (2004) 40-52
13. Dorazil-Dudzik M., Mika J., Schafer M.K., Li Y., Obara I., Wordliczek J., and Przewłocka B. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesth. Analg. 98 (2004) 1566-1573
14. Fehlings M.G., and Baptiste D.C. Current status of clinical trials for acute spinal cord injury. Injury 36 (2005) 113-122
15. Garrison C.J., Dougherty P.M., Kajander K.C., and Carlton S.M. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 565 (1991) 1-7
16. Gieseler A., Schulze A.T., Kupach K., Haroon M.F., Wolf G., Siemen D., and Kreutzmann P. Inhibitory modulation of the mitochondrial permeability transition by minocycline. Biochem Pharmacol. 77 (2009) 888-896
17. Griffin R.S., Costigan M., Brenner G.J., Ma C., Scholz J., Moss A., Allchorne A.J., Stahl G.L., and Woolf C.J. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J. Neurosci. 27 (2007) 8699-8708
18. Gwak Y.S., and Hulsebosch C.E. Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience 161 (2009) 895-903
19. Hains B.C., and Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci. 26 (2006) 4308-4317
20. Haydon, P.G., 2001. GLIA: listening and talking to the synapse. Nat. Rev. Neurosci. 2, 185-193. Review.
21. Jasmin L., Kohan L., Franssen M., Janni G., and Goff J.R. The cold plate as a test of nociceptive behaviors: description and application to the study of chronic neuropathic and inflammatory pain models. Pain 75 (1998) 367-382
22. Jin S.X., Zhuang Z.Y., Woolf C.J., and Ji R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23 (2003) 4017-4022
23. Lan L., Yuan H., Duan L., Cao R., Gao B., Shen J., Xiong Y., Chen L.W., and Rao Z.R. Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat. Neurosci Res. 57 (2007) 112-119
24. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., and Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
25. Levin M.E., Jin J.G., Ji R.R., Tong J., Pomonis J.D., Lavery D.J., Miller S.W., and Chiang L.W. Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain. Pain 137 (2008) 182-201
26. Lin C.S., Tsaur M.L., Chen C.C., Wang T.Y., Lin C.F., Lai Y.L., Hsu T.C., Pan Y.Y., Yang C.H., and Cheng J.K. Chronic intrathecal infusion of minocycline prevents the development of spinal-nerve ligation-induced pain in rats. Reg Anesth Pain Med. 32 (2007) 209-216
27. Liu J., Feng X., Yu M., Xie W., Zhao X., Li W., Guan R., and Xu J. Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain. Neurosci. Lett. 412 (2007) 268-272
28. Lu C.H., Chao P.C., Borel C.O., Yang C.P., Yeh C.C., Wong C.S., and Wu C.T. Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery. Anesth. Analg. 99 (2004) 1465-1471
29. Lundblad R., Ekstrom P., and Giercksky K.E. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock 3 (1995) 210-215
30. Ma W., and Quirion R. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain 99 (2002) 175-184
31. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6 (2005) 521-532
32. Mika J., Osikowicz M., Makuch W., and Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur. J. Pharmacol. 560 (2007) 142-149
33. Mika J., Wawrzczak-Bargiela A., Osikowicz M., Makuch W., and Przewlocka B. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav. Immun. 23 (2009) 75-84
34. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S.F., and Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23 (2003) 1026-1040
35. Mishra M.K., Ghosh D., Duseja R., and Basu A. Antioxidant potential of Minocycline in Japanese encephalitis virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem Int. 54 (2009) 464-470
36. Nakagawa T., Wakamatsu K., Zhang N., Maeda S., Minami M., Satoh M., and Kaneko S. Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 147 (2007) 445-455
37. Narita M., Yoshida T., and Nakajima M. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J. Neurochem. 97 (2006) 1337-1348
38. Neuner P., Klosner G., Schauer E., Pourmojib M., Macheiner W., Grünwald C., Knobler R., Schwarz A., Luger T.A., and Schwarz T. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83 (1994) 262-267
39. Obata H., Eisenach J.C., Hussain H., Bynum T., and Vincler M. Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. J. Pain 7 (2006) 816-822
40. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. second ed. (1986), Academic Press, New York
41. Perry, V.H., Matyszak, M.K., Fearn, S., 1993. Altered antigen expression of microglia in the aged rodent CNS. Glia 7, 60-7. Review.
42. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377 (1997) 443-464
43. Qin M., Wang J.J., Cao R., Zhang H., Duan L., Gao B., Xiong Y.F., Chen L.W., and Rao Z.R. The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat. Neurosci. Res. 55 (2006) 442-450
44. Raghavendra V., Tanga F., Rutkowski M.D., and DeLeo J.A. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104 (2003) 655-664
45. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 20 (2004) 467-473
46. Robinson A.P., White T.M., and Mason D.W. Macrophage heterogeneity in the rat as delineated by two monoclonal. Antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57 (1986) 239-247
47. Rodriguez Parkitna J., Korostynski M., Kaminska-Chowaniec D., Obara I., Mika J., Przewlocka B., and Przewlocki R. Comparison of gene expression profiles in neuropathic and inflammatory pain. J. Physiol. Pharmacol. 57 (2006) 401-414
48. Schafer M.K., Schwaeble W.J., Post C., Salvati P., Calabresi M., Sim R.B., Petry F., Loos M., and Weihe E. Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. J. Immunol. 164 (2000) 5446-5452
49. Smith, K., Leyden, J.J., 2005. Safety of doxycycline and minocycline: a systematic review. Clin. Ther. 27, 1329-1342. Review.
50. Sommer C., and Schafers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration:differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784 (1998) 154-162
51. Sterling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., and Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24 (2004) 2182-2190
52. Strassburger M., Braun H., and Reymann K.G. Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. Eur. J. Pharmacol. 592 (2008) 55-61
53. Sweitzer S., Martin D., and DeLeo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103 (2001) 529-539
54. Tanga F.Y., Raghavendra V., and DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem. Int. 45 (2004) 397-407
55. Tawfik V., and DeLeo J.A. Modulating glial activation in opioid tolerance and neuropathic pain: a role for glutamate transporters. In: DeLeo J.A., Sorkin L.S., and Watkins L.R. (Eds). Immune and glial regulation of pain (2007), IASP Press 341-361
56. Temburni M.K., and Jacob M.H. New functions for glia in the brain. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3631-3642
57. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., and Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21 (2001) 2580-2588
58. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2 (2003) 973-985
59. Watkins L.R., Milligan E.D., and Maier S.F. Spinal cord glia: new players in pain. Pain 93 (2001) 201-205
60. Watkins R., Hutchinson M.R., Johnston I.N., and Maier S.F. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 28 (2005) 661-669
61. Wie T., Sabsovich I., Guo T.Z., Shi X., Zhao R., Li W., Geis C., Sommer C., Kingery W.S., and Clark D.J. Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur. J. Pain 13 (2009) 253-262
62. Willoughby J.O., Mackenzie L., Broberg M., Thoren A.E., Medvedev A., Sims N.R., and Nilsson M. Fluorocitrate-mediated astroglial dysfunction causes seizures. J Neurosci. Res. 74 (2003) 160-166
63. Wordliczek J., Szczepanik A.M., Banach M., Turchan J., Zembala M., Siedlar M., Przewlocki R., Serednicki W., and Przewlocka B. The effect of pentoxifylline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci. 66 (2000) 1155-1164
64. Xin W.J., Weng H.R., and Dougherty P.M. Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Molecular Pain 26 (2009) 5-15
65. Xu J.T., Xin W.J., Wei X.H., Wu C.Y., Ge Y.X., Liu Y.L., Zang Y., Zhang T., Li Y.Y., and Liu X.G. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp. Neurol. 204 (2007) 355-365
66. Xu M., Bruchas M.R., Ippolito D.I., Gendron L., and Chavkin C. Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by kappa Opioid Activation of p38 Mitogen-Activated Protein Kinase. J. Neurosci. 27 (2007) 2570-2581
67. Yong V.W., Wells J., Giuliani F., Casha S., Power C., and Metz L.M. The promise of minocycline in neurology. Lancet Neurol. 3 (2004) 744-751
68. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline. derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13496-13500
69. Zabel P., Schade F.U., and Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187 (1993) 447-463
70. Zhang L., Shirayama Y., Shimizu E., Iyo M., and Hashimoto K. Protective effects of minocycline on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur. J. Pharmacol. 544 (2006) 1-9
71. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
72. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429 (2001) 23-37